Years after linking arms with Bristol Myers and both Mercks, Sutro finds its latest partner in Tokyo
Astellas and Sutro Biopharma are linking arms on a new field of antibody-drug conjugates that they hope will improve upon existing cancer immunotherapies.
The Tokyo …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.